During the past decade, Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi" #1 sponsor was "Bayer" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi" are "Venous Thromboembolism" (2 trials), "Chemotherapy-induced Thrombocytopenia" (1 trials), "Children" (1 trials), "Heart Failure" (1 trials) and "Hemophilia A" (1 trials). Many other conditions were trialed in "Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi" in a lesser frequency.

Most popular intervention types in "Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "dabigatran etexilate" (2 trials), "Baricitinib" (1 trials), "Carboplatin" (1 trials) and "Cenerimod 0.5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".